MedMen verses Hitide
look at the share count, valuation and profit per share. These two stocks should not be alike. Hitide only looses . 09 per share, MedMen looses . 81 per share and is a financial mess. Hitide needs to do a better job marketing their company to the stock market. Over the past few weeks on Ameritrade, virtually no good news. The stock does not even show it has a short position. This stock should be way over 1.00 to 3.00 a share. The public is not getting enough exposure to this company.